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Background: To summarize the diagnostic and therapeutic experiences on the patients who suffered abdominal
complications after cardiovascular surgery with cardiopulmonary bypass(CPB).
Methods: A total of 2349 consecutive patients submitted to cardiovascular surgery with CPB in our hospital
from Jan 2004 to Dec 2010 were involved. The clinical data of any abdominal complication, including its
incidence, characters, relative risks, diagnostic measures, medical or surgical management and mortality,
was retrospectively analyzed.
Results: Of all the patients, 33(1.4%) developed abdominal complications postoperatively, including 11(33.3%) cases
of paralytic ileus, 9(27.3%) of gastrointestinal haemorrhage, 2(6.1%) of gastroduodenal ulcer perforation, 2(6.1%) of
acute calculus cholecystitis, 3(9.1%) of acute acalculus cholecystitis, 4(12.1%) of hepatic dysfunction and 2(6.1%) of
ischemia bowel diseases. Of the 33 patients, 26 (78.8%) accepted medical treatment and 7 (21.2%) underwent
subsequent surgical intervention. There were 5(15.2%) deaths in this series, which was significantly higher than
the overall mortality (2.7%). Positive history of peptic ulcer, advanced ages, bad heart function, preoperative IABP
support, prolonged CPB time, low cardiac output and prolonged mechanical ventilation are the risk factors of
abdominal complications.
Conclusions: Abdominal complications after cardiovascular surgery with CPB have a low incidence but a higher
mortality. Early detection and prompt appropriate intervention are essential for the outcome of the patients.
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Abdominal complications following cardiopulmonary
bypass (CPB) have been reported since the early days of
cardiac surgery. Despite improvements in surgical tech-
niques and perfusion technologies, the incidence and
mortality have not decreased during the last two dec-
ades. It remains a significant problem in the clinical
practices. Early diagnosis and aggressive treatment is the
key to successfully reduce mortality [1]. Unfortunately,
the clinical assessment is often difficult because these
patients may be sedated, mechanically ventilated, par-
tially unresponsive, and that the usual symptoms and
signs may be masked by severe cardiac and pulmonary
conditions. In this study, we retrospectively analyzed a* Correspondence: wu_haiwei@163.com
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reproduction in any medium, provided the ortotal of 2349 patients who underwent cardiovascular
surgery with CPB at our institution from Jan 2004 to
Dec 2010, and identified the clinical characteristics of
the patients who suffered from postoperative abdominal
complications, aiming to find ways to improve the clin-
ical outcome.Methods
The consecutive patients submitted to cardiovascular
surgery with CPB in our hospital from Jan 2004 to Dec
2010 were involved. Every operation involved the use
of moderately hypothermic (28-32°C) CPB perfusion.
Myocardial preservation was achieved with cold (4°C)
crystalloid cardioplegia and warm blood using both
anterograde and retrograde techniques, which was sup-
plemented with topical hypothermia in pericardial cavity.
During cardiopulmonary bypass, haematocrit was kept
minimally at 22-25%.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of total patients
Variable Vavle














CABG + valve replacement 33
Valve replacement + Batista operation 41
Aortic surgery 79
Cardiac tumor resection 47
Congenital heart disease 366
MI myocardial infarction, CABG coronary artery bypass grafting.
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surgery and this remained in position for at least 6 h
after operation. They also received prophylactic intra-
venous antibiotics, and conventional liquid or blood
infusion if necessary. In patients with postoperative low
cardiac output (LCO), inotropic pharmacological sup-
port was required, with or without intra-aortic balloon
pump (IABP) insertion. The usual inotropic pharmaco-
logical support was dopamine/duobafendin or amrinon/
milrinone, combined with additional vasoconstrictor,
such as adrenalin or phenylephrine if necessary. Our
routine prophylaxis antacid against ulcers was done with
ranitidine on the intensive care unit (ICU). A proton
channel blocker (omeprazole) was only used in patients
with a history of ulcers. Anticoagulant therapy was
applied in all cases that had undergone valve(s) replace-
ment and/or vascular prosthesis implantation.
Abdominal complications were classified as following,
paralytic ileus, gastrointestinal haemorrhage, gastroduo-
denal perforation, acute calculus cholecystitis, acute
acalculus cholecystitis, hepatic dysfunction and ichemic
bowel disease. Patients with transient intestinal ileus,
mild hepatic dysfunction, or asymptomatic jaundice
were not included. Other rare complications such as
acute pancreatitis and pseudomembranous colitis were
not encountered in our series.
The clinical data of any abdominal complication,
including its incidence, characters, relative risks, diag-
nostic measures, medical or surgical management and
mortality, was retrospectively analyzed. Statistical anal-
ysis was performed using non-paired Student's t-test
and χ2 analysis. Data were considered significant at the
P < 0.05 level.
Results
A total of 2349 consecutive patients with CPB were
involved. The brief operative characteristics of total
patients were summarized in Table 1. A history of
gastrointestinal ulcer diseases was present in 9 patients,
59 patients were classified in NYHA class IV, and 6
patients needed preoperative IABP support. Abdominal
complications occurred postoperatively in 33 with an in-
cidence of 1.4%. This population included 19 men
(57.6%) and 14 women (42.2%) and their mean age was
43.8 years (4-86 years).
The operations associated with abdominal complications
after CPB included reparation of congenital ventricular
septal defect (1, 3.0%), correction of congenital double out-
let of right ventricle and tetralogy of Fallot (6, 18.2%),
modified Fontan procedures and total cavopulmonary con-
nections (3, 9.1%), coronary bypass grafting (3, 9.1%),
valve replacement (9, 27.3%), aortic aneurysm replace-
ment (3, 9.1%), Batista operation (1, 3%) and combined
surgery (coronary bypass grafting + valve replacement,and valve replacement + Batista operation) (7, 21.2%).
The mean aortic cross-clamping time in this group was
74.3 min (21-120 min) and the mean cardiopulmonary
bypass time was 115 min (37-210 min).
The most common events in abdominal complications
were paralytic ileus (11, 33.3%), followed by gastrointes-
tinal bleeding (9, 27.3%), gastroduodenal ulcer with per-
foration (2, 6.1%), acute calculus cholecystitis(2, 6.1%),
acute acalculus cholecystitis(3, 9.1%), hepatic dysfunc-
tion (4, 12.1%), and ischemia bowel diseases(2, 6.1%).
Most of the abdominal complications occurred late in
the postoperative period ranging from 2 to 21 days(mean
11.8 days postoperative). The incidence and the mortal-
ity of various abdominal complications are reviewed
in Table 2.
Of these 33 patients, conservative treatments were
submitted to 26 (78.8%) of them and 23 (88.5%) recov-
ered. One patient died from gastrointestinal massive
haemorrhage, and 2 died from hepatic dysfunction
combined with multiple organ failure. A total of 7
patients (21.2%) had to undergo subsequent abdominal
exploration. One case of duodenum bleeding, 2 of acute
calculus cholecystitis and 2 of perforation with gastric
ulcer were successfully surgically treated without death.
Two patients with ischemic bowel disease died in spite
of laparotomy. One of them was due to less ability to
tolerant of the procedure and the other one was due to
postoperative sepsis and circulatory failure.
Table 2 The incidence and the mortality of various abdominal complications
Complications Patients Incidence (%) Laparotomies Deaths Mortality (%)
Paralytic ileus 11 33.3 0 0 0
Gastrointestinal bleeding 9 27.3 1 1 11.1
Gastroduodenal perforation 2 6.1 2 0 0
Calculus cholecystitis 2 6.1 2 0 0
Acalculus cholecystitis 3 9.1 0 0 0
Hepatic dysfunction 4 12.1 0 2 50
Ischemic bowel disease 2 6.1 2 2 100
TOTAL 33 1.4 7 5 15.2
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plications died in all, which was significantly higher
than the overall mortality (2.7%). Ischemic bowel disease
and hepatic dysfunction mainly contributed to the
deaths (4/5, 80%).
Some of the risk factors of abdominal complications
associated with CPB are presented in Table 3. Four of 9
(44.4%) patients with postoperative gastrointestinal
bleeding had a positive history of peptic ulcer. Patients
who had developed abdominal complications tended
to be elders. The incidence in the elders (≥75 years) is
(4/74, 5.4%), which is significantly higher than those
younger patients (29/2275, 1.3%, P < 0.01). Patients with
unstable cardiac function or NYHA class IV were more
likely to develop abdominal troubles (11/59, 18.6% vs
22/2290, 1.0%; P < 0.001). Preoperative support by IABP
had been employed in 6 patients in our series, and 3 of
them (50%) suffered from the complications. In the
patients with abdominal complications, the operationsTable 3 Risk factors of abdominal complications






NYHA class IV 59 11
NYHA class ≤ III 2290 22




Low cardiac output 282 16
Normal cardiac output 2067 17
Ventilation duration
≥48 h 458 21
<48 h 1891 12were often much more complicated and the CPB time
was significantly longer than the others (115 ± 47 min vs
69 ± 29 min). Furthermore, LCO correlated with the
higher incidence of abdominal complications (16/282,
5.7% vs 17/2067, 0.8%; P < 0.001). Prolonged mechanical
ventilatory support over 48 h was also associated with
an increased risk (21/458, 4.6% vs 12/1891, 0.6%;
P < 0.001).
Discussion
Abdominal complications associated with CPB remain a
serious problem and challenge for the surgeon. These
complications are often severe and carry a high mor-
tality, resulting in a prolonged hospitalization and
increased cost. The recent improvements in surgical
technique and perioperative care may have been offset
by the increasing complexity of cardiac surgery with
older and sicker patients being operated on, as well as
the large number of reoperations being done [2,3]. This
makes the reported incidence of these complications
varies from 0.41% to 3.7% in the last 2 decades [4].
In our department, the incidence (1.4%) was consistent
with other related studies and the mortality (15.2%) was
at the low horizon of these reports (13.9-63%).
A growing consensus suggests that visceral hypoperfu-
sion during and after cardiovascular operations with
CPB seems to be the common cause for abdominal com-
plications [3]. It injures the mucosa, damages the organ,
initiates the vicious circle, and serves as a trigger for the
development of multiple organ failure which contributes
to the high mortality from these complications [5,6].
The gastrointestinal tract, the motor of systemic inflam-
mation, is particularly prone to be damaged from hypo-
perfusion and inflammatory insults [7]. Most of the
patients who had a long history of congestive heart fail-
ure with poor cardiac performance have fewer abilities
to tolerate or compensate for ischemia and anoxemia.
Transient episodes of hypotension and indispensable
hemodilution during CPB result in shunting blood away
from the splanchnic area towards areas of higher prior-
ity, for example, brain. These factors induce the hepatic
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flow reduced [8]. CPB activates the inflammatory cells
and stimulate these cells to release cytokines, which
promote systemic fluid sequestration and splanchnic
edema formation, and contribute to bowel microvascular
barrier injury which induces the bacterial invasion and
following endotoxin transfusion [9,10]. Using of vaso-
constricting agents is known to worsen peripheral tissue
perfusion. Taking drugs such as muscle relaxants,
analgesics, and sedatives can cause enteral hypomobility.
Routine administration of digitalis also induces mesen-
teric hypoperfusion.
Identification of risk factors for the development of
abdominal complications after CPB has remained largely
speculative. According to both our results and earlier
studies, clinical risk factors seem to associate with
following factors, advanced ages, history of peptic ulcer
disease, cardiac function insufficient, the use of IABP
support, prolonged CPB time, postoperative LCO and
respiration dysfunction with prolonged ventilatory
support [11]. Although for each complication there may
be individual risk factors, as a general principle, those
factors that lead to reduced peripheral blood delivery
and tissue oxygenation increase the incidence signifi-
cantly. The perioperative LCO syndrome is of great
importance in the initiation of an incipient abdominal
complication [12].
Abdominal complications after cardiovascular surgery
are life-threatening. They are often parts of several post-
operative events that lead to or consequences of LCO,
respiratory failure, renal failure, or central nervous
system deficits, ultimately result in death. As the clinical
signs may be misleading and the complementary investi-
gations may be misinterpreted, the early diagnosis is
difficult in the immediate postoperative period and the
patients are often critically severe at the time when
the complications were recognized [13]. Managements
of these serious, complicated and interwoven problems
are always challenging. There-after higher mortality is
inevitable. Therefore, the possibility of these critical con-
ditions must be kept in mind, especially in patients with
one or more predisposing factors, to allow early detection
and treatment at a still curable stage. From a practical
standpoint, patients with abdominal pain or distension
should be suspected and closely monitored and the usual
diagnostic measures should be undertaken appropriately.
Initial treatment is usually conservative, but when it
fails, prompt surgical intervention is obligatory. The im-
portance of early exploration cannot be overemphasized
and a low threshold to early laparotomy is strongly
recommended. Indeed, effective and timely operation
may be life-saving in patients who are poorly able to
compensate the severe haemodynamic disturbances of
a refractory abdominal complication, such as majorbleeding or sepsis. Experience suggests that reluctance
and hesitation because the patient “had recent cardio-
vascular surgery” have no place if improved outcome
is truly sought [14]. Placement of the abdominal inci-
sion requires special attention. The lower end of the
sternal incision should be protected from contact with
the abdominal incision to prevent contamination and
reduce the risk of sternal infection and mediastinitis.
Prophylaxis against bacterial endocarditis should be insti-
tuted, especially in patients with prosthetic vessel or
valve(s). Patients who are anticoagulated require judi-
cious reversal and reinstutition of anticoagulation after
abdominal surgery.
Recently research showed that pulsatile flow during
CPB may ameliorate intraoperative hypoperfusion, main-
tain splanchnic capillary perfusion better, and decrease
the ischaemic visceral injury by mimicking the native
circulation pattern. Vigorous gastric acid reduction may
decrease the risk of these complications [15]. Patients
in higher risk should have vigorous monitoring of gastric
pH, thus prophylactic H2-receptor antagonists or proton
pump inhibitors should routinely be given in the postopera-
tive period. The optimisation of cardiac pump function and
peripheral tissue oxygenation using preoperative IABP in
patients with low CO more liberally and, possibly, infusion
of energy-rich substrates may reduce the incidence of
postoperative low flow states and consequently the risk of
abdominal complications.
Conclusions
In conclusion, abdominal complications after cardiovas-
cular surgery with CPB have a low incidence but a higher
mortality. Early detection and prompt appropriate inter-
vention are essential for the outcome of the patients.
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